{"id":48719,"title":"Laboratory Protocols","title_html":"<p>Laboratory Protocols<\/p>","image":{"source":"https:\/\/www.protocols.io\/img\/default_protocol.png","placeholder":"https:\/\/www.protocols.io\/img\/default_protocol.png"},"doi":"dx.doi.org\/10.17504\/protocols.io.bttpnnmn","doi_status":2,"uri":"laboratory-protocols-bttpnnmn","type_id":1,"template_id":4,"published_on":1622736361,"parent_protocols":[],"parent_collections":[],"cited_protocols":[],"version_id":0,"version_data":{"id":"0","code":"bttpnnmn","parent_id":0,"parent_uri":null,"is_same_owner":false,"has_pending_merge_request":false,"has_approved_merge_request":false},"created_on":1617138600,"modified_on":null,"categories":null,"public":1,"is_unlisted":0,"creator":{"name":"Sandra Helena  Suescun-Carrero","affiliation":"Grupo de Investigaci\u00f3n del Laboratorio de Salud P\u00fablica de Boyac\u00e1, Secretaria de Salud de Boyac\u00e1, Tunja, Colombia.  Doctorado en Metodolog\u00eda de la Investigaci\u00f3n Biom\u00e9dica y Salud P\u00fablica, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain. ","affiliations":[{"affiliation":"Grupo de Investigaci\u00f3n del Laboratorio de Salud P\u00fablica de Boyac\u00e1, Secretaria de Salud de Boyac\u00e1, Tunja, Colombia.  Doctorado en Metodolog\u00eda de la Investigaci\u00f3n Biom\u00e9dica y Salud P\u00fablica, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain. ","url":"","is_default":1}],"username":"sandra-helena--suescuncarrero","note":null,"link":"https:\/\/doi.org\/10.1371\/journal.pntd.0009483","image":{"source":"\/img\/avatars\/013.png","placeholder":"\/img\/avatars\/013.png"},"badges":[{"id":2,"image":{"source":"\/img\/badges\/bronze.svg","placeholder":"\/img\/badges\/bronze.svg"},"name":"Author"}],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"journal":null,"journal_name":null,"journal_link":null,"article_citation":null,"has_versions":0,"link":"https:\/\/doi.org\/10.1371\/journal.pntd.0009483","total_collections":0,"number_of_steps":2,"authors":[{"name":"Lyda Pilar Salamanca-Cardozo","affiliation":"Grupo de Investigaci\u00f3n del Laboratorio de Salud P\u00fablica de Boyac\u00e1, Secretaria de Salud de Boyac\u00e1, Tunja, Colombia. ","affiliations":[],"username":"w2z2c4v2q2z2","note":"","link":null,"image":{"source":"\/img\/avatars\/002.png","placeholder":"\/img\/avatars\/002.png"},"badges":[],"verified":1,"is_verified_user":true,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Mar\u00eda-Jesus Pinazo","affiliation":"Barcelona Institute for Global Health (ISGlobal), Hospital Clinic - University of Barcelona, Barcelona, Spain. ","affiliations":[],"username":"w2z2c4v2q203","note":"","link":null,"image":{"source":"\/img\/avatars\/007.png","placeholder":"\/img\/avatars\/007.png"},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Lluis Armadans-Gil.","affiliation":"Servicio de Medicina Preventiva y Epidemiolog\u00eda, Hospital Universitari Vall d\u2019Hebron - Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain. ","affiliations":[],"username":"w2z2c4v2r2s2","note":"","link":null,"image":{"source":"\/img\/avatars\/001.png","placeholder":"\/img\/avatars\/001.png"},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Sandra Helena  Suescun-Carrero","affiliation":"Grupo de Investigaci\u00f3n del Laboratorio de Salud P\u00fablica de Boyac\u00e1, Secretaria de Salud de Boyac\u00e1, Tunja, Colombia.  Doctorado en Metodolog\u00eda de la Investigaci\u00f3n Biom\u00e9dica y Salud P\u00fablica, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain. ","affiliations":[],"username":"sandra-helena--suescuncarrero","note":"","link":null,"image":{"source":"\/img\/avatars\/013.png","placeholder":"\/img\/avatars\/013.png"},"badges":[],"verified":1,"is_verified_user":true,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false}],"versions":[],"groups":[],"is_owner":1,"has_subprotocols":0,"is_subprotocol":0,"is_bookmarked":0,"can_claim_authorship":0,"can_accept_authorship":0,"can_be_copied":1,"can_remove_fork":1,"fork_id":null,"url":"https:\/\/www.protocols.io\/view\/laboratory-protocols-bttpnnmn","forks_count":{"private":0,"public":0},"access":{"can_view":1,"can_remove":0,"can_add":0,"can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":1,"can_move":1,"can_move_outside":1,"can_transfer":1,"can_download":1,"is_locked":0},"guid":"43626660919C11EBBA666BE0ED0E15E6","state_version_id":91,"steps":[{"id":1153380,"guid":"49D73B60919C11EBBA666BE0ED0E15E6","previous_id":null,"previous_guid":null,"modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"987E86453FED46828D1C38C453899163","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"E0AAA95518874902817CD16E63E2403E","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>The reference diagnostic strategy utilized in the present study is based on conventional serological tests suggested by the National Parasitology Reference Laboratory of the National Health Institute (Instito Nacional de Salud, or INS) of Colombia, and is routinely used in the CD monitoring program of the LDSP. All samples were analyzed using the ELISA Chagas III GrupoBios\u00d2tests [informed sensitivity, 100%; specificity, 100%]  and with the Chagas ELISA IgG+IgM I Vircell\u00d2tests [informed sensitivity, 100%; specificity, 98%] [30,31].In cases in which discordant results were found between the two ELISA tests, an IIF test was done, which uses epimastigotes of the Colombian <\/span><span style = \"font-style:italic;\">T. cruzi <\/span><span>strains DTU and TcI as antigens, when the results of this technique were positive, case was considered to be confirmed.The tests were done in serum samples in the LDSP, following the manufacturer\u2019s instructions; the laboratory complies with the internal quality control standards of the method, using material for quality control of the MQC and with external quality controls and aptitude tests done by the INS and Proasecal.The results of the tests were interpreted as either positive or negative. <\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1153402,"guid":"20F87960919D11EBA5DD89639413440B","previous_id":1153380,"previous_guid":"49D73B60919C11EBBA666BE0ED0E15E6","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"DFBD8EC930034756AA9E671AB8C87BAA","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"A0AEA5A197644E05A46BEF4FDFFC89DF","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>There are several RDT's for detecting infection by <\/span><span style = \"font-style:italic;\">T.cruzi<\/span><span> which have the advantages described above over conventional tests and that have high sensitivities and specificities according to several authors. Thus, in the present study, all samples were analyzed using two immunochromatographic diagnostic tests based on different antigens: Chagas Detect Plus (InBios International Inc., Seattle, USA) \u00d2CDP, which uses a multi-epitope antigen, and Chagas Stat-Pak (Chembio Inc., Medford USA) \u00d2CSP, which employs a combination of recombinant proteins. Small quantities of whole blood from finger puncture were used to carry out the RDT's. In order to evaluate cross-reactivity with leishmaniasis<\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":null,"critical_id":null,"duration":0}],"document":"","materials":[],"description":"<div class = \"text-blocks\"><div class = \"text-block\"><div class = \"justify\" style = \"text-align:justify\"><span style = \"font-weight:bold;\">Objective.<\/span><span>To evaluate diagnostic precision of two rapid diagnostic tests (RDT's) on patients with chronic Chagas disease.<\/span><\/div><style>\n\t\t\t\t\t\t\t  .justify:after {\n\t\t\t\t\t\t\t    content: \"\";\n\t\t\t\t\t\t\t    display:inline-block;\n\t\t\t\t\t\t\t    width: 100%;\n\t\t\t\t\t\t\t  }\n\t\t\t\t\t\t\t<\/style><\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:justify\"><span style = \"font-weight:bold;\">Methodology. <\/span><span>Prospective study with the following inclusion criteria: subjects older than 3 years, signed informed consent. Exclusion criterion: subjects could not have previously received treatment for infection with <\/span><span style = \"font-style:italic;\">T. cruzi<\/span><span>. The study population were participants in a screening process undertaken in rural and urban zones of the department Boyac\u00e1, Colombia. Two RDT\u2019s were performed to all participants: the Chagas Detect Plus InBios (CDP) and the Chagas Stat-Pak (CSP) and as a reference standard the ELISA Chagas III GrupoBios and the Chagas ELISA IgG+IgM I Vircell tests wereused.In the case of discordant results between the two ELISA tests, an indirect immunofluorescence was done. <\/span><\/div><style>\n\t\t\t\t\t\t\t  .justify:after {\n\t\t\t\t\t\t\t    content: \"\";\n\t\t\t\t\t\t\t    display:inline-block;\n\t\t\t\t\t\t\t    width: 100%;\n\t\t\t\t\t\t\t  }\n\t\t\t\t\t\t\t<\/style><\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:justify\"><span style = \"font-weight:bold;\">Results. <\/span><span>Three hundred-five (305) subjects were included in the study (38 patients with leishmaniasis), of which 215 tested negative for <\/span><span style = \"font-style:italic;\">T cruzi<\/span><span> and 90 tested positive according to the reference standard.The sensitivity of the RDT\u2019s were 100% (CI 95% 95.9 \u2013 100), and the specificity of the CDP was 99.1% (CI 95% 96.6 \u2013 99.8) and for CSP was 100% (CI 95% 98.3 \u2013 100). The agreement of CDP was 99.5% and for CSP was 100% with Kappa values of (k=99.1; CI 95% 92.6-99.8%) and (k=100; CI 95% 94.3-100), respectively. RDT\u2019s did not present cross-reactions with samples from patients who were positive for leishmaniasis. <\/span><\/div><style>\n\t\t\t\t\t\t\t  .justify:after {\n\t\t\t\t\t\t\t    content: \"\";\n\t\t\t\t\t\t\t    display:inline-block;\n\t\t\t\t\t\t\t    width: 100%;\n\t\t\t\t\t\t\t  }\n\t\t\t\t\t\t\t<\/style><\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:justify\"><span style = \"font-weight:bold;\">Conclusions<\/span><\/div><style>\n\t\t\t\t\t\t\t  .justify:after {\n\t\t\t\t\t\t\t    content: \"\";\n\t\t\t\t\t\t\t    display:inline-block;\n\t\t\t\t\t\t\t    width: 100%;\n\t\t\t\t\t\t\t  }\n\t\t\t\t\t\t\t<\/style><\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:justify\">The findings demonstrate excellent results from the RDT\u2019s in terms of validity, safety, and reproducibility. The results obtained provide evidence for the recommendation for using these tests in a Colombian epidemiological context principally in endemic areas in which laboratory installations necessary to perform conventional tests are not available, or they are scarce and to help in diagnosing chronic Chagas disease in order to provide access to treatment as soon as possible.<\/div><style>\n\t\t\t\t\t\t\t  .justify:after {\n\t\t\t\t\t\t\t    content: \"\";\n\t\t\t\t\t\t\t    display:inline-block;\n\t\t\t\t\t\t\t    width: 100%;\n\t\t\t\t\t\t\t  }\n\t\t\t\t\t\t\t<\/style><\/div><\/div>","changed_on":1622736361}